Literature DB >> 10412727

Association between hyperlipidemia and microalbuminuria in essential hypertension.

V M Campese1, S Bianchi, R Bigazzi.   

Abstract

BACKGROUND: Some patients with essential hypertension manifest greater than normal urinary albumin excretion (UAE). A few retrospective studies have suggested that there is an association between microalbuminuria and cardiovascular risk. The reasons for this association are not well established, and they are the object of this review.
RESULTS: We found that hypertensive patients with microalbuminuria manifest greater levels of blood pressure, particularly at night. Serum levels of cholesterol, triglycerides, and uric acid in patients with microalbuminuria were higher than levels in those with normal UAE, whereas levels of high-density lipoprotein cholesterol in patients with microalbuminuria were lower than levels in patients with normal UAE. Patients with microalbuminuria manifest a greater incidence of insulin resistance, and thicker carotid arteries. After a follow-up of seven years we observed that 12 cardiovascular events occurred among 54 (21.3%) patients with microalbuminuria, and only two such events among 87 patients with normal UAE (P < 0.0002). Stepwise logistical regression analysis showed that UAE, cholesterol level and diastolic blood pressure were independent predictors of the cardiovascular outcome. The rate of clearance of creatinine from patients with microalbuminuria decreased more than did that from those with normal urinary albumin excretion.
CONCLUSIONS: These studies suggest that hypertensive individuals with microalbuminuria manifest a variety of biochemical and hormonal derangements with pathogenic potential, which result in greater incidence of cardiovascular events and a greater decline in renal function than do patients with normal UAE.

Entities:  

Mesh:

Year:  1999        PMID: 10412727

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  9 in total

1.  Screening and prevention of chronic kidney disease.

Authors:  Errol D Crook; David O Washington; John M Flack
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

Review 2.  HMG-CoA reductase inhibitors and the kidney.

Authors:  Vito M Campese; Bassel Hadaya; Josephine Chiu
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

3.  High-normal albuminuria and risk of heart failure in the community.

Authors:  Saul Blecker; Kunihiro Matsushita; Anna Köttgen; Laura R Loehr; Alain G Bertoni; L Ebony Boulware; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2011-05-06       Impact factor: 8.860

Review 4.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

5.  Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.

Authors:  Cornelis Boersma; Maarten J Postma; Sipke T Visser; Jarir Atthobari; Paul E de Jong; Lolkje T W de Jong-van den Berg; Ron T Gansevoort
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

6.  Low-Grade Albuminuria Is Associated with Metabolic Syndrome and Its Components in Middle-Aged and Elderly Chinese Population.

Authors:  Jie Zhang; Yuhong Chen; Yu Xu; Mian Li; Tiange Wang; Baihui Xu; Jichao Sun; Min Xu; Jieli Lu; Yufang Bi
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

7.  LIPITENSION: Interplay between dyslipidemia and hypertension.

Authors:  Jamshed J Dalal; T N C Padmanabhan; Piyush Jain; Shiva Patil; Hardik Vasnawala; Ashish Gulati
Journal:  Indian J Endocrinol Metab       Date:  2012-03

8.  Kidney injury molecule-1 and microalbuminuria levels in Zambian population: biomarkers of kidney injury.

Authors:  Mildred Zulu; Trevor Kaile; Timothy Kantenga; Chisanga Chileshe; Panji Nkhoma; Musalula Sinkala
Journal:  Pan Afr Med J       Date:  2016-05-13

9.  Stepped-wedge cluster-randomised controlled trial to assess the cardiovascular health effects of a managed aquifer recharge initiative to reduce drinking water salinity in southwest coastal Bangladesh: study design and rationale.

Authors:  Abu Mohd Naser; Leanne Unicomb; Solaiman Doza; Kazi Matin Ahmed; Mahbubur Rahman; Mohammad Nasir Uddin; Shamshad B Quraishi; Shahjada Selim; Mohammad Shamsudduha; William Burgess; Howard H Chang; Matthew O Gribble; Thomas F Clasen; Stephen P Luby
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.